Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
3.035
+0.045 (1.51%)
Nov 21, 2024, 3:08 PM EST - Market open
Fulcrum Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Hold
Price Target
$7.44
Upside
+145.14%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Reiterates $4 | Hold | Reiterates | $4 | +31.80% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $4 | Hold | Reiterates | $4 | +31.80% | Nov 14, 2024 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $15 → $4 | Buy → Hold | Downgrades | $15 → $4 | +31.80% | Sep 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $17 → $4 | Strong Buy → Hold | Downgrades | $17 → $4 | +31.80% | Sep 13, 2024 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $4 | Buy → Hold | Downgrades | $4 | +31.80% | Sep 12, 2024 |
| B of A Securities | B of A Securities | Hold → Sell Downgrades $10 → $2 | Hold → Sell | Downgrades | $10 → $2 | -34.10% | Sep 12, 2024 |
| Stifel | Stifel | Strong Buy → Hold Downgrades $22 → $3 | Strong Buy → Hold | Downgrades | $22 → $3 | -1.15% | Sep 12, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Sep 12, 2024 |
| B of A Securities | B of A Securities | Sell → Hold Upgrades $5 → $10 | Sell → Hold | Upgrades | $5 → $10 | +229.49% | Sep 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +460.13% | Aug 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $23 | Buy | Reiterates | $23 | +657.83% | Jul 10, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $23 | Buy | Initiates | $23 | +657.83% | May 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +460.13% | May 14, 2024 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Buy Upgrades $6 → $15 | Hold → Strong Buy | Upgrades | $6 → $15 | +394.23% | May 14, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $16 → $14 | Buy | Maintains | $16 → $14 | +361.29% | May 14, 2024 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Buy Upgrades $15 | Hold → Strong Buy | Upgrades | $15 | +394.23% | May 13, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.